Regarding the Eph/ephrin signaling pathway exploitation in glioma therapeutic strategies, EPHA2 expression in high-grade gliomas makes it a potential therapeutic target, with compounds like Dasatinib showing promising results in patient survival [87,88]. Here, EPHA1 is linked to glioma.